<VariationArchive VariationID="1427364" VariationName="NC_000011.9:g.(?_72145096)_(72145518_?)del" VariationType="Deletion" Accession="VCV001427364" Version="7" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-10" DateCreated="2022-03-28" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1440899" VariationID="1427364">
      <GeneList>
        <Gene Symbol="CLPB" FullName="ClpB family mitochondrial disaggregase" GeneID="81570" HGNC_ID="HGNC:30664" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11q13.4</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="72285495" stop="72434531" display_start="72285495" display_stop="72434531" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="72003468" stop="72145723" display_start="72003468" display_stop="72145723" Strand="-" />
          </Location>
          <OMIM>616254</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000011.9:g.(?_72145096)_(72145518_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11q13.4</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" innerStart="72145096" innerStop="72145518" display_start="72145096" display_stop="72145518" variantLength="423" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.(?_72145096)_(72145518_?)del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.(?_72145096)_(72145518_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000011.9:g.(?_72145096)_(72145518_?)del AND 3-methylglutaconic aciduria, type VIIB" Accession="RCV001933669" Version="5">
        <ClassifiedConditionList TraitSetID="20957">
          <ClassifiedCondition DB="MedGen" ID="C5676893">3-methylglutaconic aciduria, type VIIB</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-07-26" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-07-26" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-03-28" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">25597510</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28687938</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="20957" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33015" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">3-methylglutaconic aciduria, type VII, with cataracts, neurologic involvement and neutropenia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">3-methylglutaconic aciduria, type VIIB</ElementValue>
                <XRef ID="MONDO:0014561" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">3-methylglutaconic aciduria with cataracts, neurologic involvement and neutropenia</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MGCA7</ElementValue>
                <XRef Type="MIM" ID="616271" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">MGCA7B</ElementValue>
                <XRef Type="MIM" ID="616271" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">CLPB (caseinolytic peptidase B) deficiency is characterized by neurologic involvement and neutropenia, which can range from severe to mild. In severe CLPB deficiency, death usually occurs at a few months of age due to significant neonatal neurologic involvement (hyperekplexia or absence of voluntary movements, hypotonia or hypertonia, swallowing problems, respiratory insufficiency, and epilepsy) and severe neutropenia associated with life-threatening infections. Individuals with moderate CLPB deficiency present with neurologic abnormalities in infancy including hypotonia and feeding problems, and develop spasticity, a progressive movement disorder (ataxia, dystonia, and/or dyskinesia), epilepsy, and intellectual disability. Neutropenia is variable, but not life threatening. In those with mild CLPB deficiency there is no neurologic involvement, intellect is normal, neutropenia is mild and intermittent, and life expectancy is normal.</Attribute>
                <XRef ID="NBK396257" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17767" />
                <XRef ID="17767" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">27891836</ID>
                <ID Source="BookShelf">NBK396257</ID>
              </Citation>
              <XRef ID="445038" DB="Orphanet" />
              <XRef ID="C5676893" DB="MedGen" />
              <XRef ID="MONDO:0014561" DB="MONDO" />
              <XRef Type="MIM" ID="616271" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4221208" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-09" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="NM_030813.5_11_Deletion (exon 1)_72145095_72145518|MedGen:C4225393" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002203010" DateUpdated="2024-06-09" DateCreated="2022-03-28" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-07-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25597510</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28687938</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with CLPB-related conditions. This variant is a gross deletion of the genomic region encompassing exon(s) 1 of the CLPB gene, which includes the initiator codon. The 5' end of this event is unknown as it extends beyond the assayed region for this gene and therefore may encompass additional genes. The 3' boundary is likely confined to intron 1 of the CLPB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CLPB are known to be pathogenic (PMID: 25597510, 28687938).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CLPB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.(?_72145096)_(72145518_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C4225393" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14505679</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4221208" TraitType="Disease" MappingType="XRef" MappingValue="C4225393" MappingRef="MedGen">
        <MedGen CUI="C5676893" Name="3-methylglutaconic aciduria, type VIIB" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

